2023 annual financial data
Lakefront Biotherapeutics 2023 Operating margin
Lakefront Biotherapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -36.82%.
Operating income was -88,263,000 EUR and net income was 211,697,000 EUR.
Operating cash flow was -405,970,000 EUR.
Get free Lakefront Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 239,724,000 EUR
- Operating income
- -88,263,000 EUR
- Net income
- 211,697,000 EUR
- Operating cash flow
- -405,970,000 EUR